O
Overview
Oncora AI provides software-as-a-service tools that help oncology teams collect, analyze, and act on patient data within existing clinical workflows. Its suite includes Oncora Patient Care for clinical documentation and billing, Oncora Evidence for clinical research, and Oncora Registry for building cancer registries. The platform uses data analytics and machine learning to identify patterns and support treatment decisions, reporting, and research workflows. By focusing on oncology data, partnerships, and industry recognition, its goal is to improve cancer treatment outcomes and accelerate clinical discoveries.
Work here?Claim your company
Simplify's take
What believers are saying
- Oncora launched Registry AI in May 2025 and expanded its AI product line.
- MedCity News reported a 2025 MD Anderson collaboration, its biggest endeavor to date.
- Oncora said in 2025 its client base doubled, signaling accelerating demand.
What critics are saying
- Oncora Medical reported only $1.9 million total capital, last filed in September 2017.
- EHR vendors and registry incumbents can bundle similar workflows, compressing Oncora's pricing.
- If enterprise adoption stalls beyond 2026, Oncora risks becoming a demo-only niche tool.
What makes Oncora AI unique
- Oncora AI specializes in oncology registry automation, not generic hospital software.
- July 2025 reincorporation sharpened its focus on AI-powered clinical data abstraction.
- Its tools integrate pathology, radiology, and clinical notes into NAACCR coding.
Help us improve and share your feedback! Did you find this helpful?